Institut fuer Klinische Transfusionsmedizin und Immungenetik Ulm gGmbH

At Institut fuer Klinische Transfusionsmedizin und Immungenetik Ulm gGmbH, clinical research is centered on immune system diseases, with a strong focus on Paroxysmal Nocturnal Hemoglobinuria. The studies are designed to better understand this rare condition and to assess new treatment options that may improve long-term disease control and patient well-being.

• Research on Paroxysmal Nocturnal Hemoglobinuria and related immune-mediated blood disorders
• Evaluation of the safety and tolerability of new therapies for long-term use
• Clinical work aimed at improving treatment effectiveness for patients with chronic immune system conditions

With 8 trials and 96 investigators involved, the site in Ulm contributes to advancing care for rare hematologic and immunologic diseases through focused clinical evaluation.